In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small cell lung cancer (NSCLC) […]
The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says […]
Now that a COVID-19 vaccine has arrived, many of us are eagerly awaiting the day we get our first shot. However, figuring out when you’re eligible, […]